“… 2 , 3 Crohn's disease, which was previously almost synonymous with malnutrition, is now characterised by overweight and obesity as well as sarcopenic obesity as a sign of malnutrition and loss of muscle mass. 1 , 4 Along with all of its well‐known consequences, obesity in IBD patients significantly compromises the application of most of new treatment modalities, such as biological therapy. 5 , 6 , 7 Obesity can also compromise the results of surgical treatment such as bariatric surgery in IBD.…”